Literature DB >> 19952059

Dynamic hyperinflation during daily activities: does COPD global initiative for chronic obstructive lung disease stage matter?

Jorien D C Hannink1, Hanneke A C van Helvoort, P N Richard Dekhuijzen, Yvonne F Heijdra.   

Abstract

BACKGROUND: One of the contributors to exercise limitation in COPD is dynamic hyperinflation. Although dynamic hyperinflation appears to occur during several exercise protocols in COPD and seems to increase with increasing disease severity, it is unknown whether dynamic hyperinflation occurs at different severity stages according to the Global initiative for chronic Obstructive Lung Disease (GOLD) in daily life. The present study, therefore, aimed to compare dynamic hyperinflation between COPD GOLD stages II-IV during daily activities.
METHODS: Thirty-two clinically stable patients with COPD GOLD II (n = 10), III (n = 12), and IV (n = 10) participated in this study. Respiratory physiology during a daily activity was measured at patients' homes with Oxycon Mobile. Inspiratory capacity maneuvers were performed at rest, at 2-min intervals during the activity, and at the end of the activity. Change in inspiratory capacity is commonly used to reflect change in end-expiratory lung volume (DeltaEELV) and, therefore, dynamic hyperinflation. The combination of static and dynamic hyperinflation was reflected by inspiratory reserve volume (IRV) during the activity.
RESULTS: Overall, increase in EELV occurred in GOLD II-IV without significant difference between the groups. There was a tendency for a smaller DeltaEELV in GOLD IV. DeltaEELV was inversely related to static hyperinflation. IRV during the daily activity was related to the level of airflow obstruction.
CONCLUSIONS: Dynamic hyperinflation occurs independent of GOLD stage during real-life daily activities. The combination of static and dynamic hyperinflation, however, increases with increasing airflow obstruction.

Entities:  

Mesh:

Year:  2009        PMID: 19952059     DOI: 10.1378/chest.09-1847

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Effect of Yoga Breathing (Pranayama) on Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Controlled Trial.

Authors:  David A Kaminsky; Kalpalatha K Guntupalli; Joan Lippmann; Stephanie M Burns; Melissa A Brock; Joan Skelly; Michael DeSarno; Heidi Pecott-Grimm; Ali Mohsin; Catherine LaRock-McMahon; Penney Warren; Martha C Whitney; Nicola A Hanania
Journal:  J Altern Complement Med       Date:  2017-07-17       Impact factor: 2.579

2.  Dynamic hyperinflation correlates with exertional oxygen desaturation in patients with chronic obstructive pulmonary disease.

Authors:  Muhammad Ahsan Zafar; Wayne Tsuang; Laura Lach; William Eschenbacher; Ralph J Panos
Journal:  Lung       Date:  2013-01-03       Impact factor: 2.584

3.  Effectiveness of Energy Conservation Techniques in Patients with COPD.

Authors:  Ann Sylvia Louise Wingårdh; Carina Göransson; Sven Larsson; Frode Slinde; Lowie E G W Vanfleteren
Journal:  Respiration       Date:  2020-04-09       Impact factor: 3.580

4.  Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort.

Authors:  Mehdi Rambod; Janos Porszasz; Barry J Make; James D Crapo; Richard Casaburi
Journal:  Chest       Date:  2011-09-29       Impact factor: 9.410

5.  Cardiac injury in patients with COPD presenting with dyspnea: a pilot study.

Authors:  Esosa Odigie-Okon; Bryan Jordan; Sylvester Dijeh; Armand Wolff; Razvan Dadu; Priyanka Lall; Stuart Zarich; Yaw Amoateng-Adjepong; Constantine A Manthous
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-11-09

6.  ACCORD COPD II: a randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patients.

Authors:  Stephen I Rennard; Paul D Scanlon; Gary T Ferguson; Ludmyla Rekeda; Brian T Maurer; Esther Garcia Gil; Cynthia F Caracta
Journal:  Clin Drug Investig       Date:  2013-12       Impact factor: 2.859

7.  Effects of body mass index on task-related oxygen uptake and dyspnea during activities of daily life in COPD.

Authors:  Anouk W Vaes; Frits M E Franssen; Kenneth Meijer; Martijn W J Cuijpers; Emiel F M Wouters; Erica P A Rutten; Martijn A Spruit
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

Review 8.  Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.

Authors:  Amnon Ariel; Alan Altraja; Andrey Belevskiy; Piotr W Boros; Edvardas Danila; Matjaz Fležar; Vladimir Koblizek; Zvi G Fridlender; Kosta Kostov; Alvils Krams; Branislava Milenkovic; Attila Somfay; Ruzena Tkacova; Neven Tudoric; Ruxandra Ulmeanu; Arschang Valipour
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-21

9.  Oxygen and ventilatory output during several activities of daily living performed by COPD patients stratified according to disease severity.

Authors:  Antonio A M Castro; Elias F Porto; Vinícius C Iamonti; Gérson F de Souza; Oliver A Nascimento; José R Jardim
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

10.  Ventilatory demand and dynamic hyperinflation induced during ADL-based tests in Chronic Obstructive Pulmonary Disease patients.

Authors:  Karoliny Dos Santos; Aline A Gulart; Anelise B Munari; Manuela Karloh; Anamaria F Mayer
Journal:  Braz J Phys Ther       Date:  2016-06-16       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.